跳至主要内容
临床试验/NL-OMON39508
NL-OMON39508已完成不适用

Hypertension, Small Vessel Disease (SVD) and cognitive function. - Hypertension, Small Vessel Disease (SVD) and cognitive function.

Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 112 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
112

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Inclusion criteria
  • - Patients who participated in the HYBRiD- study
  • - Consent for being contacted for follow-up studies
  • - Essential hypertension:
  • o Use of antihypertensive medication at first visit of the hypertension clinic, or
  • o Office blood pressure: *140 and/ or *90 mmHg (average of 3 measurements with intervals of 2 minutes minimum, or
  • o ABPM blood pressure: *125 and/ or *80 mmHg (average of 24 hours).
  • - Caucasian
  • - Age between 18 and 90 years
  • - Ambulant

排除标准

  • - - Cerebrovascular abnormalities in anamnesis
  • o TIA in 6 months before anamnesis
  • o Brain infarction
  • o Haemorrhage (subarachnoid or intracerebral)
  • - Contra indications for MRI
  • o Heart valve prosthesis
  • o Pacemaker
  • o Intracerebral clips (aneurysm)
  • o Intra-ocular metal pieces
  • o Cochlear implant
  • o Claustrophobia
  • - When the patient does not appreciate to receive the results of the study, in particular if abnormalities are found during MRI or neuropsychological assessment, which are of great importance for the patients health.

研究者

发起方
Medisch Universitair Ziekenhuis Maastricht

相似试验